LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

First Meeting of Nanomedicine Society

By Biotechdaily staff writers
Posted on 24 Aug 2005
The American Academy of Nanomedicine (AANM, Washington, DC, USA) held its first annual meeting at Johns Hopkins University (Baltimore, MD, USA) on August 15 and 16, 2005.

Founded in early 2005, the AANM is an international society created to advance both clinical applications and research in the field of nanomedicine. The two-day program focused on the applications of nanomedicine in a variety of fields including diagnostic, clinical, oncology, pharmacology, basic and experimental nanomedicine, and the policy and commercialization of nanomedicine.

The keynote speaker was James Baker, Jr., M.D., from the Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan (Ann Arbor, USA), who lectured on "What is Nanomedicine?” He further described how nanoscale synthetic materials with biologic systems provide both great promises and risks for biologic sciences.

The second address was given by Dr. Ueli Aebi from the U.S. National Center of Competence in Research, Mueller Institute (Basel, Switzerland), in a lecture entitled "Imaging, Measuring, and Manipulating Living Matter by Minimally Invasive Nanoprobes.”

AANM's membership represents basic and clinical investigators, molecular biologists, engineers, physicians, and others with an interest in the field. It is the only society devoted specifically to the emerging field of nanomedicine. The Academy's first meeting provided a forum to exchange ideas, communicate new findings, and encouraged collaboration among the diverse disciplines represented in nanomedicine.




Related Links:
American Academy of Nanomedicine

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma

Latest BioResearch News

Population-Scale Proteomics Study Identifies New Genetic-Protein Links
24 Aug 2005  |   BioResearch

Circulating Tumor DNA Helps Identify Targets for Personalized Immunotherapy
24 Aug 2005  |   BioResearch

Researchers Classify 108 Lysosomal Disorders in Updated Diagnostic Framework
24 Aug 2005  |   BioResearch